BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 37371723)

  • 1. Uncovering the Secrets of Prostate Cancer's Radiotherapy Resistance: Advances in Mechanism Research.
    Lyu F; Shang SY; Gao XS; Ma MW; Xie M; Ren XY; Liu MZ; Chen JY; Li SS; Huang L
    Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Redox-responsive nanoparticles enhance radiation therapy by altering multifaceted radio-resistance mechanisms in human castration-resistant prostate cancer cells and xenografts.
    Lip H; Amini MA; Zetrini A; Cai P; Abbasi AZ; Bristow RG; Rauth AM; Wu XY
    Radiother Oncol; 2022 May; 170():213-223. PubMed ID: 35227733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SMC1A is associated with radioresistance in prostate cancer and acts by regulating epithelial-mesenchymal transition and cancer stem-like properties.
    Yadav S; Kowolik CM; Lin M; Zuro D; Hui SK; Riggs AD; Horne DA
    Mol Carcinog; 2019 Jan; 58(1):113-125. PubMed ID: 30242889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual benefit of supplementary oral 5-aminolevulinic acid to pelvic radiotherapy in a syngenic prostate cancer model.
    Miyake M; Tanaka N; Hori S; Ohnishi S; Takahashi H; Fujii T; Owari T; Ohnishi K; Iida K; Morizawa Y; Gotoh D; Itami Y; Nakai Y; Inoue T; Anai S; Torimoto K; Aoki K; Fujimoto K
    Prostate; 2019 Mar; 79(4):340-351. PubMed ID: 30450646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming drug resistance and treating advanced prostate cancer.
    Semenas J; Allegrucci C; Boorjian SA; Mongan NP; Persson JL
    Curr Drug Targets; 2012 Sep; 13(10):1308-23. PubMed ID: 22746994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infiltrating mast cells increase prostate cancer chemotherapy and radiotherapy resistances via modulation of p38/p53/p21 and ATM signals.
    Xie H; Li C; Dang Q; Chang LS; Li L
    Oncotarget; 2016 Jan; 7(2):1341-53. PubMed ID: 26625310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Transcription Factors Zeb1 and Snail Induce Cell Malignancy and Cancer Stem Cell Phenotype in Prostate Cells, Increasing Androgen Synthesis Capacity and Therapy Resistance.
    López-Moncada F; Castellón EA; Contreras HR
    Adv Exp Med Biol; 2022; 1393():51-64. PubMed ID: 36587301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testicular orphan nuclear receptor 4 is associated with the radio-sensitivity of prostate cancer.
    Yu S; Wang M; Ding X; Xia L; Chen B; Chen Y; Zhang Z; Niu Y; Li G; Chang C
    Prostate; 2015 Oct; 75(14):1632-42. PubMed ID: 26178291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cells recruited by castration-induced inflammation activation accelerate prostate cancer hormone resistance via chemokine ligand 5 secretion.
    Yu Y; Zhang Q; Ma C; Yang X; Lin R; Zhang H; Liu Y; Han Z; Cheng J
    Stem Cell Res Ther; 2018 Sep; 9(1):242. PubMed ID: 30257726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Height, body mass index and prostate cancer risk and mortality by way of detection and cancer risk category.
    Jochems SHJ; Stattin P; Häggström C; Järvholm B; Orho-Melander M; Wood AM; Stocks T
    Int J Cancer; 2020 Dec; 147(12):3328-3338. PubMed ID: 32525555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer.
    Heidenreich A; Bastian PJ; Bellmunt J; Bolla M; Joniau S; van der Kwast T; Mason M; Matveev V; Wiegel T; Zattoni F; Mottet N;
    Eur Urol; 2014 Feb; 65(2):467-79. PubMed ID: 24321502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-Coding RNAs Set a New Phenotypic Frontier in Prostate Cancer Metastasis and Resistance.
    Altschuler J; Stockert JA; Kyprianou N
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orphan nuclear receptor RORγ confers doxorubicin resistance in prostate cancer.
    Gao M; Guo L; Wang H; Huang J; Han F; Xiang S; Wang J
    Cell Biol Int; 2020 Oct; 44(10):2170-2176. PubMed ID: 32584473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced radiosensitization of enzalutamide via schedule dependent administration to androgen-sensitive prostate cancer cells.
    Ghashghaei M; Niazi TM; Heravi M; Bekerat H; Trifiro M; Paliouras M; Muanza T
    Prostate; 2018 Jan; 78(1):64-75. PubMed ID: 29134684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recent developments in radiation oncology-integrating radiation physics and molecular radiobiology advances into clinical radiotherapy practice and beyond].
    Teh BS; Paulino A; Butler EB
    Ai Zheng; 2008 Aug; 27(8):885-93. PubMed ID: 18710628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulating the dose-rate differently affects the responsiveness of human epithelial prostate- and mesenchymal rhabdomyosarcoma-cancer cell line to radiation.
    Petragnano F; Pietrantoni I; Di Nisio V; Fasciani I; Del Fattore A; Capalbo C; Cheleschi S; Tini P; Orelli S; Codenotti S; Mazzei MA; D'Ermo G; Pannitteri G; Tombolini M; De Cesaris P; Riccioli A; Filippini A; Milazzo L; Vulcano F; Fanzani A; Maggio R; Marampon F; Tombolini V
    Int J Radiat Biol; 2020 Jun; 96(6):823-835. PubMed ID: 32149569
    [No Abstract]   [Full Text] [Related]  

  • 17. Cancer stem cells (CSCs): key player of radiotherapy resistance and its clinical significance.
    Hoque S; Dhar R; Kar R; Mukherjee S; Mukherjee D; Mukerjee N; Nag S; Tomar N; Mallik S
    Biomarkers; 2023 Mar; 28(2):139-151. PubMed ID: 36503350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.
    Mottet N; Bellmunt J; Bolla M; Briers E; Cumberbatch MG; De Santis M; Fossati N; Gross T; Henry AM; Joniau S; Lam TB; Mason MD; Matveev VB; Moldovan PC; van den Bergh RCN; Van den Broeck T; van der Poel HG; van der Kwast TH; Rouvière O; Schoots IG; Wiegel T; Cornford P
    Eur Urol; 2017 Apr; 71(4):618-629. PubMed ID: 27568654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer Stemness/Epithelial-Mesenchymal Transition Axis Influences Metastasis and Castration Resistance in Prostate Cancer: Potential Therapeutic Target.
    Castellón EA; Indo S; Contreras HR
    Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-145 Modulates Tumor Sensitivity to Radiation in Prostate Cancer.
    Gong P; Zhang T; He D; Hsieh JT
    Radiat Res; 2015 Dec; 184(6):630-8. PubMed ID: 26632856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.